id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02740361
|
6:23:chronic_disease
|
very severe depression that would interfere with the ability to participate in the study (based on clinical judgment by the physician at the recruitment site)
| 1
|
[
"very",
"severe",
"depression",
"that",
"would",
"interfere",
"with",
"the",
"ability",
"to",
"participate",
"in",
"the",
"study",
"(",
"based",
"on",
"clinical",
"judgment",
"by",
"the",
"physician",
"at",
"the",
"recruitment",
"site",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02584647
|
18:28:cancer
|
Active secondary malignancy unless the malignancy is not expected to interfere with the evaluation of safety and is approved by the Sponsor
| 1
|
[
"Active",
"secondary",
"malignancy",
"unless",
"the",
"malignancy",
"is",
"not",
"expected",
"to",
"interfere",
"with",
"the",
"evaluation",
"of",
"safety",
"and",
"is",
"approved",
"by",
"the",
"Sponsor"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02503722
|
1:31:chronic_disease
|
Uncontrolled diabetes mellitus
| 1
|
[
"Uncontrolled",
"diabetes",
"mellitus"
] |
[
2,
2,
2
] |
NCT01802346
|
44:61:cancer,63:75:treatment,103:114:treatment,106:114:treatment,129:147:treatment
|
Subjects do not need to have measurable or evaluable disease; chemotherapy may be administered in the neoadjuvant, adjuvant, or metastatic setting
| 1
|
[
"Subjects",
"do",
"not",
"need",
"to",
"have",
"measurable",
"or",
"evaluable",
"disease",
";",
"chemotherapy",
"may",
"be",
"administered",
"in",
"the",
"neoadjuvant",
",",
"adjuvant",
",",
"or",
"metastatic",
"setting"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02319369
|
19:45:treatment,160:174:treatment,230:268:treatment
|
Participated in a therapeutic clinical study within a washout time of 2 weeks or 5 half-lives of the drug/biologic (whichever is longer) before starting study drug treatment under this protocol, or current participation in other therapeutic investigational procedures
| 1
|
[
"Participated",
"in",
"a",
"therapeutic",
"clinical",
"study",
"within",
"a",
"washout",
"time",
"of",
"2",
"weeks",
"or",
"5",
"half-lives",
"of",
"the",
"drug/biologic",
"(",
"whichever",
"is",
"longer",
")",
"before",
"starting",
"study",
"drug",
"treatment",
"under",
"this",
"protocol",
",",
"or",
"current",
"participation",
"in",
"other",
"therapeutic",
"investigational",
"procedures"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02635893
|
1:4:chronic_disease,
|
SCI ( ≥1 month of injury)
| 1
|
[
"SCI",
"(",
"≥1",
"month",
"of",
"injury",
")"
] |
[
2,
0,
0,
0,
0,
0,
0
] |
NCT02592707
|
14:24:chronic_disease
|
Diagnosis of thymic NET
| 1
|
[
"Diagnosis",
"of",
"thymic",
"NET"
] |
[
0,
0,
2,
2
] |
NCT02417701
|
26:34:chronic_disease,,
|
Patients with controlled diabetes are allowed on study; controlled diabetes is defined as fetal bovine serum (FBS) =< 130 mg/dL in the context of this study
| 1
|
[
"Patients",
"with",
"controlled",
"diabetes",
"are",
"allowed",
"on",
"study",
";",
"controlled",
"diabetes",
"is",
"defined",
"as",
"fetal",
"bovine",
"serum",
"(",
"FBS",
")",
"=",
"<",
"130",
"mg/dL",
"in",
"the",
"context",
"of",
"this",
"study"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03073785
|
48:54:treatment,
|
Patients may not be receiving or have received Zometa during/or within 3 weeks prior to treatment with Zometa
| 1
|
[
"Patients",
"may",
"not",
"be",
"receiving",
"or",
"have",
"received",
"Zometa",
"during/or",
"within",
"3",
"weeks",
"prior",
"to",
"treatment",
"with",
"Zometa"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02312245
|
14:24:cancer,,71:96:cancer,100:131:cancer
|
Other active malignancy =< 3 years prior to registration; EXCEPTIONS: non-melanotic skin cancer or carcinoma-in-situ of the cervix
| 1
|
[
"Other",
"active",
"malignancy",
"=",
"<",
"3",
"years",
"prior",
"to",
"registration",
";",
"EXCEPTIONS",
":",
"non-melanotic",
"skin",
"cancer",
"or",
"carcinoma-in-situ",
"of",
"the",
"cervix"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3
] |
NCT02975986
|
76:89:chronic_disease,,
|
In the Control group (N=10), we will include volunteers with no history of stone disease matched for age (within 5 years)
| 1
|
[
"In",
"the",
"Control",
"group",
"(",
"N=10",
")",
",",
"we",
"will",
"include",
"volunteers",
"with",
"no",
"history",
"of",
"stone",
"disease",
"matched",
"for",
"age",
"(",
"within",
"5",
"years",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01534104
|
1:33:cancer,
|
Primary or secondary brain tumor (enhancing mass lesion ± nonenhancing abnormality), known or suspected, located near (< 2 cm) any portion of the motor cortex
| 1
|
[
"Primary",
"or",
"secondary",
"brain",
"tumor",
"(",
"enhancing",
"mass",
"lesion",
"±",
"nonenhancing",
"abnormality",
")",
",",
"known",
"or",
"suspected",
",",
"located",
"near",
"(",
"<",
"2",
"cm",
")",
"any",
"portion",
"of",
"the",
"motor",
"cortex"
] |
[
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02128906
|
16:40:chronic_disease
|
no symptomatic congestive heart failure
| 1
|
[
"no",
"symptomatic",
"congestive",
"heart",
"failure"
] |
[
0,
0,
2,
2,
2
] |
NCT02427581
|
1:44:cancer
|
Invasive cancer in the contralateral breast
| 1
|
[
"Invasive",
"cancer",
"in",
"the",
"contralateral",
"breast"
] |
[
3,
3,
3,
3,
3,
3
] |
NCT02088554
|
1:16:chronic_disease
|
Porcelain aorta
| 1
|
[
"Porcelain",
"aorta"
] |
[
2,
2
] |
NCT02857218
|
18:28:cancer,
|
History of other malignancy in the past 2 years
| 1
|
[
"History",
"of",
"other",
"malignancy",
"in",
"the",
"past",
"2",
"years"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02457845
|
7:10:chronic_disease
|
Known HIV seropositivity
| 1
|
[
"Known",
"HIV",
"seropositivity"
] |
[
0,
2,
0
] |
NCT02000115
|
14:36:treatment,77:92:treatment,117:151:treatment,223:243:chronic_disease,255:270:chronic_disease
|
Pre-existing prosthetic heart valve or other implant in any valve position, prosthetic ring, severe circumferential mitral annular calcification (MAC) which is continuous with calcium in the LVOT, severe (greater than 3+) mitral insufficiency, or severe mitral stenosis with pulmonary compromise
| 1
|
[
"Pre-existing",
"prosthetic",
"heart",
"valve",
"or",
"other",
"implant",
"in",
"any",
"valve",
"position",
",",
"prosthetic",
"ring",
",",
"severe",
"circumferential",
"mitral",
"annular",
"calcification",
"(",
"MAC",
")",
"which",
"is",
"continuous",
"with",
"calcium",
"in",
"the",
"LVOT",
",",
"severe",
"(",
"greater",
"than",
"3+",
")",
"mitral",
"insufficiency",
",",
"or",
"severe",
"mitral",
"stenosis",
"with",
"pulmonary",
"compromise"
] |
[
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02542202
|
27:39:treatment,32:39:treatment,41:54:treatment,56:68:treatment,
|
Patients must have had no radiotherapy, immunotherapy, chemotherapy or therapy with targeted agents within the last 1 month
| 1
|
[
"Patients",
"must",
"have",
"had",
"no",
"radiotherapy",
",",
"immunotherapy",
",",
"chemotherapy",
"or",
"therapy",
"with",
"targeted",
"agents",
"within",
"the",
"last",
"1",
"month"
] |
[
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02181257
|
42:52:treatment
|
For patients who are monitored with home Spirometry (subject to Institutional Review Board (IRB) approval)
| 1
|
[
"For",
"patients",
"who",
"are",
"monitored",
"with",
"home",
"Spirometry",
"(",
"subject",
"to",
"Institutional",
"Review",
"Board",
"(",
"IRB",
")",
"approval",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02933034
|
6:33:chronic_disease
|
have NYHA Grade IV heart failure
| 1
|
[
"have",
"NYHA",
"Grade",
"IV",
"heart",
"failure"
] |
[
0,
2,
2,
2,
2,
2
] |
NCT03097536
|
10:26:chronic_disease
|
comorbid eating disorders
| 1
|
[
"comorbid",
"eating",
"disorders"
] |
[
0,
2,
2
] |
NCT01625923
|
25:36:treatment,42:74:treatment,94:125:treatment,
|
Subject has never had a gastrectomy, nor major gastric surgical procedure or any evidence of bowel obstruction or strictures within the previous 12 months
| 1
|
[
"Subject",
"has",
"never",
"had",
"a",
"gastrectomy",
",",
"nor",
"major",
"gastric",
"surgical",
"procedure",
"or",
"any",
"evidence",
"of",
"bowel",
"obstruction",
"or",
"strictures",
"within",
"the",
"previous",
"12",
"months"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02926248
|
15:30:chronic_disease,38:51:chronic_disease,53:62:chronic_disease,,
|
Patients with hepatic disease (known liver disease, cirrhosis, and/or AST/ALT>60)
| 1
|
[
"Patients",
"with",
"hepatic",
"disease",
"(",
"known",
"liver",
"disease",
",",
"cirrhosis",
",",
"and/or",
"AST/ALT",
">",
"60",
")"
] |
[
0,
0,
2,
2,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02555189
|
1:64:treatment,
|
Prior isotope therapy with strontium-89, samarium or radium-223 within 12 weeks of enrollment
| 1
|
[
"Prior",
"isotope",
"therapy",
"with",
"strontium-89",
",",
"samarium",
"or",
"radium-223",
"within",
"12",
"weeks",
"of",
"enrollment"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01754857
|
,,,,158:167:treatment
|
FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP even if they have had a successful vasectomy
| 1
|
[
"FCBP",
"must",
"also",
"agree",
"to",
"ongoing",
"pregnancy",
"testing",
";",
"men",
"must",
"agree",
"to",
"use",
"a",
"latex",
"condom",
"during",
"sexual",
"contact",
"with",
"a",
"FCBP",
"even",
"if",
"they",
"have",
"had",
"a",
"successful",
"vasectomy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01972919
|
1:27:cancer,29:46:cancer,50:68:chronic_disease
|
Distant metastatic disease, second malignancy or peritoneal seeding
| 1
|
[
"Distant",
"metastatic",
"disease",
",",
"second",
"malignancy",
"or",
"peritoneal",
"seeding"
] |
[
3,
3,
3,
0,
3,
3,
0,
2,
2
] |
NCT02452268
|
26:37:cancer,38:48:cancer,57:67:cancer,,124:131:treatment
|
Histologically confirmed solid tumor malignancy that is metastatic or unresectable and have progressed on at least 1 prior therapy and for whom standard curative or palliative measures do not exist or are associated with minimal subject survival benefit
| 1
|
[
"Histologically",
"confirmed",
"solid",
"tumor",
"malignancy",
"that",
"is",
"metastatic",
"or",
"unresectable",
"and",
"have",
"progressed",
"on",
"at",
"least",
"1",
"prior",
"therapy",
"and",
"for",
"whom",
"standard",
"curative",
"or",
"palliative",
"measures",
"do",
"not",
"exist",
"or",
"are",
"associated",
"with",
"minimal",
"subject",
"survival",
"benefit"
] |
[
0,
0,
3,
3,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01742299
|
58:67:treatment
|
Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures
| 1
|
[
"Willingness",
"and",
"ability",
"to",
"comply",
"with",
"scheduled",
"visits",
",",
"treatment",
"plans",
"and",
"any",
"other",
"study",
"procedures"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01803451
|
25:33:chronic_disease
|
healthy control without diabetes
| 1
|
[
"healthy",
"control",
"without",
"diabetes"
] |
[
0,
0,
0,
2
] |
NCT02013492
|
77:93:chronic_disease,107:131:chronic_disease,133:157:chronic_disease,159:177:chronic_disease,182:219:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02737202
|
10:30:treatment
|
Previous lung transplantation
| 1
|
[
"Previous",
"lung",
"transplantation"
] |
[
0,
1,
1
] |
NCT02555189
|
26:36:cancer,
|
Patient has a concurrent malignancy or malignancy within 3 years of enrollment
| 1
|
[
"Patient",
"has",
"a",
"concurrent",
"malignancy",
"or",
"malignancy",
"within",
"3",
"years",
"of",
"enrollment"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02512718
|
12:15:allergy_name,17:21:allergy_name,26:29:allergy_name,30:45:allergy_name
|
allergy to egg, fish, or soy/legume products
| 1
|
[
"allergy",
"to",
"egg",
",",
"fish",
",",
"or",
"soy/legume",
"products"
] |
[
0,
0,
4,
0,
4,
0,
0,
4,
4
] |
NCT02525861
|
44:68:chronic_disease,,,
|
The participant has clinically significant congestive heart failure with New York Heart Association (NYHA) Class III/IV symptoms
| 1
|
[
"The",
"participant",
"has",
"clinically",
"significant",
"congestive",
"heart",
"failure",
"with",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"Class",
"III/IV",
"symptoms"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02346929
|
1:19:chronic_disease
|
mental retardation
| 1
|
[
"mental",
"retardation"
] |
[
2,
2
] |
NCT01522768
|
15:48:cancer
|
Asymptomatic, central nervous system metastases
| 1
|
[
"Asymptomatic",
",",
"central",
"nervous",
"system",
"metastases"
] |
[
0,
0,
3,
3,
3,
3
] |
NCT01245712
|
1:36:treatment
|
Prior radiation to the index breast
| 1
|
[
"Prior",
"radiation",
"to",
"the",
"index",
"breast"
] |
[
1,
1,
1,
1,
1,
1
] |
NCT02389309
|
1:27:treatment,,56:70:treatment,,88:102:treatment
|
Stem cell transplant (SCT): at least 8 weeks following autologous SCT and 12 weeks for allogeneic SCT
| 1
|
[
"Stem",
"cell",
"transplant",
"(",
"SCT",
")",
":",
"at",
"least",
"8",
"weeks",
"following",
"autologous",
"SCT",
"and",
"12",
"weeks",
"for",
"allogeneic",
"SCT"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1
] |
NCT02912572
|
1:20:cancer
|
Endometrial cancers that are MSS as determined by normal immunohistochemical nuclear expression of all the mismatch repair genes MSH2, MSH6, MLH1 and PMS2
| 1
|
[
"Endometrial",
"cancers",
"that",
"are",
"MSS",
"as",
"determined",
"by",
"normal",
"immunohistochemical",
"nuclear",
"expression",
"of",
"all",
"the",
"mismatch",
"repair",
"genes",
"MSH2",
",",
"MSH6",
",",
"MLH1",
"and",
"PMS2"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01554371
|
,,68:79:chronic_disease
|
QTc prolongation >480 msec (Bazett's Formula) or congenitally long QT syndrome
| 1
|
[
"QTc",
"prolongation",
">",
"480",
"msec",
"(",
"Bazett",
"'s",
"Formula",
")",
"or",
"congenitally",
"long",
"QT",
"syndrome"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02357784
|
36:58:treatment
|
planning to undergo placement of a sacral nerve modulator
| 1
|
[
"planning",
"to",
"undergo",
"placement",
"of",
"a",
"sacral",
"nerve",
"modulator"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02477124
|
21:34:treatment,38:48:treatment,52:55:chronic_disease,79:83:treatment,92:101:treatment,105:120:cancer
|
Patients undergoing cervicography OR colposcopy OR VIA OR patients undergoing LEEP for the treatment of cervical cancer
| 1
|
[
"Patients",
"undergoing",
"cervicography",
"OR",
"colposcopy",
"OR",
"VIA",
"OR",
"patients",
"undergoing",
"LEEP",
"for",
"the",
"treatment",
"of",
"cervical",
"cancer"
] |
[
0,
0,
1,
0,
1,
0,
2,
0,
0,
0,
1,
0,
0,
1,
0,
3,
3
] |
NCT02579044
|
,,169:178:treatment
|
Sexually active male and female subjects of reproductive potential must agree to use a medically accepted form of birth control while on study and up to 10 weeks after treatment
| 1
|
[
"Sexually",
"active",
"male",
"and",
"female",
"subjects",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"a",
"medically",
"accepted",
"form",
"of",
"birth",
"control",
"while",
"on",
"study",
"and",
"up",
"to",
"10",
"weeks",
"after",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02408861
|
1:12:cancer,,,
|
Solid Tumor Expansion Cohort: CD4+ cell count greater than 200 cells/mm^3 obtained within 2 weeks prior to enrollment at any U.S. laboratory that has a clinical laboratory improvement amendments (CLIA) certification or its equivalent
| 1
|
[
"Solid",
"Tumor",
"Expansion",
"Cohort",
":",
"CD4+",
"cell",
"count",
"greater",
"than",
"200",
"cells/mm^3",
"obtained",
"within",
"2",
"weeks",
"prior",
"to",
"enrollment",
"at",
"any",
"U.S.",
"laboratory",
"that",
"has",
"a",
"clinical",
"laboratory",
"improvement",
"amendments",
"(",
"CLIA",
")",
"certification",
"or",
"its",
"equivalent"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02471430
|
13:35:chronic_disease
|
Evidence of coronary heart disease
| 1
|
[
"Evidence",
"of",
"coronary",
"heart",
"disease"
] |
[
0,
0,
2,
2,
2
] |
NCT02130687
|
1:24:chronic_disease,,
|
Impaired renal function (eGFR< 50mL/min/1.73m2 as determined by the MDRD equation)
| 1
|
[
"Impaired",
"renal",
"function",
"(",
"eGFR",
"<",
"50mL/min/1.73m2",
"as",
"determined",
"by",
"the",
"MDRD",
"equation",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03085004
|
52:56:chronic_disease
|
solid mass component within or associated with the cyst
| 1
|
[
"solid",
"mass",
"component",
"within",
"or",
"associated",
"with",
"the",
"cyst"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02451423
|
16:25:treatment
|
The effects of MPDL3280A on the developing human fetus are unknown
| 1
|
[
"The",
"effects",
"of",
"MPDL3280A",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01538966
|
1:11:chronic_disease,39:42:treatment,47:71:treatment,
|
Acromegaly patients who have received SRL and dopamine agonist therapy, after a 6 week washout period of the dopamine agonist
| 1
|
[
"Acromegaly",
"patients",
"who",
"have",
"received",
"SRL",
"and",
"dopamine",
"agonist",
"therapy",
",",
"after",
"a",
"6",
"week",
"washout",
"period",
"of",
"the",
"dopamine",
"agonist"
] |
[
2,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02217345
|
22:54:treatment
|
Contraindications to magnetic resonance imaging (MRI)
| 1
|
[
"Contraindications",
"to",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")"
] |
[
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT01245712
|
1:35:cancer,44:51:cancer,55:63:cancer
|
Non-epithelial breast malignancies such as sarcoma or lymphoma
| 1
|
[
"Non-epithelial",
"breast",
"malignancies",
"such",
"as",
"sarcoma",
"or",
"lymphoma"
] |
[
3,
3,
3,
0,
0,
3,
0,
3
] |
NCT02323191
|
1:23:cancer
|
Leptomeningeal disease
| 1
|
[
"Leptomeningeal",
"disease"
] |
[
3,
3
] |
NCT01626079
|
1:30:chronic_disease,38:49:chronic_disease,51:66:chronic_disease,68:79:chronic_disease
|
Infiltrative cardiomyopathies (e.g., amyloidosis, hemochromatosis, sarcoidosis)
| 1
|
[
"Infiltrative",
"cardiomyopathies",
"(",
"e.g.",
",",
"amyloidosis",
",",
"hemochromatosis",
",",
"sarcoidosis",
")"
] |
[
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
0
] |
NCT03053908
|
1:14:chronic_disease
|
hydrocephalus
| 1
|
[
"hydrocephalus"
] |
[
2
] |
NCT02774421
|
28:40:treatment
|
who have been treated with chemotherapy at time of recurrence
| 1
|
[
"who",
"have",
"been",
"treated",
"with",
"chemotherapy",
"at",
"time",
"of",
"recurrence"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01505062
|
29:39:allergy_name
|
Contraindications to use of anesthesia (local or general, as appropriate)
| 1
|
[
"Contraindications",
"to",
"use",
"of",
"anesthesia",
"(",
"local",
"or",
"general",
",",
"as",
"appropriate",
")"
] |
[
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03037346
|
23:45:cancer,,
|
Diagnosis of invasive gynecologic malignancy stages 1-4
| 1
|
[
"Diagnosis",
"of",
"invasive",
"gynecologic",
"malignancy",
"stages",
"1-4"
] |
[
0,
0,
0,
3,
3,
0,
0
] |
NCT02106052
|
5:16:chronic_disease
|
All MS subtypes
| 1
|
[
"All",
"MS",
"subtypes"
] |
[
0,
2,
2
] |
NCT02942095
|
34:59:chronic_disease,71:96:chronic_disease,111:130:chronic_disease,144:168:chronic_disease,170:185:chronic_disease,190:211:chronic_disease,
|
Evidence of current uncontrolled cardiovascular conditions, including uncontrolled hypertension, uncontrolled cardiac arrhythmias, symptomatic congestive heart failure, unstable angina, or myocardial infarction within the past 6 months
| 1
|
[
"Evidence",
"of",
"current",
"uncontrolled",
"cardiovascular",
"conditions",
",",
"including",
"uncontrolled",
"hypertension",
",",
"uncontrolled",
"cardiac",
"arrhythmias",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
",",
"or",
"myocardial",
"infarction",
"within",
"the",
"past",
"6",
"months"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT03138733
|
28:53:treatment
|
Requirement for continuous renal-replacement therapy
| 1
|
[
"Requirement",
"for",
"continuous",
"renal-replacement",
"therapy"
] |
[
0,
0,
0,
1,
1
] |
NCT01821690
|
4:13:treatment,
|
No surgeries planned during the 91-day participation
| 1
|
[
"No",
"surgeries",
"planned",
"during",
"the",
"91-day",
"participation"
] |
[
0,
1,
0,
0,
0,
0,
0
] |
NCT02953860
|
1:38:treatment,40:51:treatment,53:60:treatment,62:74:treatment,76:88:treatment,90:97:treatment,99:106:treatment,108:115:treatment,117:124:treatment,126:132:treatment
|
Prior treatment with an anti-androgen (abiraterone, ARN-509, bicalutamide, enzalutamide, ODM-201, TAK-448, TAK-683, TAK-700, VT-464)
| 1
|
[
"Prior",
"treatment",
"with",
"an",
"anti-androgen",
"(",
"abiraterone",
",",
"ARN-509",
",",
"bicalutamide",
",",
"enzalutamide",
",",
"ODM-201",
",",
"TAK-448",
",",
"TAK-683",
",",
"TAK-700",
",",
"VT-464",
")"
] |
[
1,
1,
1,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT02095184
|
40:53:cancer,,
|
Evidence of hormone sensitive, ER rich primary tumor defined by an Allred score of ≥6
| 1
|
[
"Evidence",
"of",
"hormone",
"sensitive",
",",
"ER",
"rich",
"primary",
"tumor",
"defined",
"by",
"an",
"Allred",
"score",
"of",
"≥6"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02709980
|
1:19:chronic_disease
|
psychotic disorder requiring admission
| 1
|
[
"psychotic",
"disorder",
"requiring",
"admission"
] |
[
2,
2,
0,
0
] |
NCT02469129
|
,,36:38:treatment
|
Non-measurable disease (< 1 cm) by CT (Kinetic Studies Arm only; disease-free participants can be enrolled in the Dosimetry Studies Arm)
| 1
|
[
"Non-measurable",
"disease",
"(",
"<",
"1",
"cm",
")",
"by",
"CT",
"(",
"Kinetic",
"Studies",
"Arm",
"only",
";",
"disease-free",
"participants",
"can",
"be",
"enrolled",
"in",
"the",
"Dosimetry",
"Studies",
"Arm",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02257138
|
31:53:chronic_disease
|
Active clinically serious and uncontrolled infection
| 1
|
[
"Active",
"clinically",
"serious",
"and",
"uncontrolled",
"infection"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02530034
|
,,,,,,,,,305:314:treatment
|
Women of child-bearing potential (i.e., women who are pre-menopausal or not surgically sterile) must use acceptable contraceptive methods (abstinence, intrauterine device [IUD], oral contraceptive or double barrier device), and must have a negative urine pregnancy test within 2 weeks prior to beginning treatment on this trial
| 1
|
[
"Women",
"of",
"child-bearing",
"potential",
"(",
"i.e.",
",",
"women",
"who",
"are",
"pre-menopausal",
"or",
"not",
"surgically",
"sterile",
")",
"must",
"use",
"acceptable",
"contraceptive",
"methods",
"(",
"abstinence",
",",
"intrauterine",
"device",
"[",
"IUD",
"]",
",",
"oral",
"contraceptive",
"or",
"double",
"barrier",
"device",
")",
",",
"and",
"must",
"have",
"a",
"negative",
"urine",
"pregnancy",
"test",
"within",
"2",
"weeks",
"prior",
"to",
"beginning",
"treatment",
"on",
"this",
"trial"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02122185
|
28:38:cancer,,
|
concurrent active invasive malignancy or one previously diagnosed with a greater than 30% chance of recurrence in the next two years
| 1
|
[
"concurrent",
"active",
"invasive",
"malignancy",
"or",
"one",
"previously",
"diagnosed",
"with",
"a",
"greater",
"than",
"30",
"%",
"chance",
"of",
"recurrence",
"in",
"the",
"next",
"two",
"years"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02021279
|
86:104:chronic_disease,106:124:chronic_disease,129:135:chronic_disease
|
Subject has a known neurologic or medical condition affecting bladder function (e.g. multiple sclerosis, spinal cord injury, or stroke with residual neurologic deficit)
| 1
|
[
"Subject",
"has",
"a",
"known",
"neurologic",
"or",
"medical",
"condition",
"affecting",
"bladder",
"function",
"(",
"e.g",
".",
"multiple",
"sclerosis",
",",
"spinal",
"cord",
"injury",
",",
"or",
"stroke",
"with",
"residual",
"neurologic",
"deficit",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02762266
|
1:36:treatment
|
Prior radiofrequency ablation (RFA) to index lesion
| 1
|
[
"Prior",
"radiofrequency",
"ablation",
"(",
"RFA",
")",
"to",
"index",
"lesion"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02438995
|
,,124:133:treatment,,
|
Patients must agree to use a medically effective method of contraception during and for a period of three months after the treatment period. A pregnancy test will be performed on each premenopausal female of childbearing potential immediately prior to entry into the research study
| 1
|
[
"Patients",
"must",
"agree",
"to",
"use",
"a",
"medically",
"effective",
"method",
"of",
"contraception",
"during",
"and",
"for",
"a",
"period",
"of",
"three",
"months",
"after",
"the",
"treatment",
"period",
".",
"A",
"pregnancy",
"test",
"will",
"be",
"performed",
"on",
"each",
"premenopausal",
"female",
"of",
"childbearing",
"potential",
"immediately",
"prior",
"to",
"entry",
"into",
"the",
"research",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01950234
|
1:10:treatment,16:29:treatment,44:66:treatment,96:105:treatment,
|
Treatment with dalfampridine or compounded 4-aminopyridine (4-AP) will be permitted as long as treatment has been ongoing and stable for at least 3 months prior to randomization
| 1
|
[
"Treatment",
"with",
"dalfampridine",
"or",
"compounded",
"4-aminopyridine",
"(",
"4-AP",
")",
"will",
"be",
"permitted",
"as",
"long",
"as",
"treatment",
"has",
"been",
"ongoing",
"and",
"stable",
"for",
"at",
"least",
"3",
"months",
"prior",
"to",
"randomization"
] |
[
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464436
|
1:24:chronic_disease,28:40:chronic_disease,60:84:chronic_disease,140:147:treatment
|
Active ocular infection or inflammation, or any history of intraocular inflammation, that would expose subject to risk during or following surgery
| 1
|
[
"Active",
"ocular",
"infection",
"or",
"inflammation",
",",
"or",
"any",
"history",
"of",
"intraocular",
"inflammation",
",",
"that",
"would",
"expose",
"subject",
"to",
"risk",
"during",
"or",
"following",
"surgery"
] |
[
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03098394
|
35:65:chronic_disease
|
Signs or symptoms consistent with sexually transmitted infection
| 1
|
[
"Signs",
"or",
"symptoms",
"consistent",
"with",
"sexually",
"transmitted",
"infection"
] |
[
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01200940
|
1:34:chronic_disease
|
Psychiatric or cognitive disorder that will, in the opinion of the investigators, limit the subject's ability to provide informed consent, or to comply with study procedures
| 1
|
[
"Psychiatric",
"or",
"cognitive",
"disorder",
"that",
"will",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigators",
",",
"limit",
"the",
"subject",
"'s",
"ability",
"to",
"provide",
"informed",
"consent",
",",
"or",
"to",
"comply",
"with",
"study",
"procedures"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03002519
|
12:22:cancer,
|
History of malignancy (other than the disease that required the HCT) within 5 years prior to screening
| 1
|
[
"History",
"of",
"malignancy",
"(",
"other",
"than",
"the",
"disease",
"that",
"required",
"the",
"HCT",
")",
"within",
"5",
"years",
"prior",
"to",
"screening"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02847689
|
1:42:chronic_disease
|
Intraventricular Hemorrhage Grades III-IV
| 1
|
[
"Intraventricular",
"Hemorrhage",
"Grades",
"III-IV"
] |
[
2,
2,
2,
2
] |
NCT02332291
|
1:9:chronic_disease
|
dementia
| 1
|
[
"dementia"
] |
[
2
] |
NCT02074436
|
19:34:treatment
|
Patient receiving anticoagulation
| 1
|
[
"Patient",
"receiving",
"anticoagulation"
] |
[
0,
0,
1
] |
NCT01859819
|
1:43:cancer
|
Primary Mediastinal B-Cell Lymphoma (PMBL)
| 1
|
[
"Primary",
"Mediastinal",
"B-Cell",
"Lymphoma",
"(",
"PMBL",
")"
] |
[
3,
3,
3,
3,
3,
0,
0
] |
NCT02515110
|
,56:68:treatment,,
|
Women who are not postmenopausal or have not undergone hysterectomy must have a documented negative pregnancy test within 14 days prior to study registration
| 1
|
[
"Women",
"who",
"are",
"not",
"postmenopausal",
"or",
"have",
"not",
"undergone",
"hysterectomy",
"must",
"have",
"a",
"documented",
"negative",
"pregnancy",
"test",
"within",
"14",
"days",
"prior",
"to",
"study",
"registration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02343549
|
11:21:cancer
|
Any other malignancy
| 1
|
[
"Any",
"other",
"malignancy"
] |
[
0,
0,
3
] |
NCT02595996
|
1:21:chronic_disease
|
Secondary lymphedema
| 1
|
[
"Secondary",
"lymphedema"
] |
[
2,
2
] |
NCT01481974
|
36:50:allergy_name,52:64:allergy_name,68:80:allergy_name
|
Have any known hypersensitivity to prostaglandins, prostacyclin or treprostinil
| 1
|
[
"Have",
"any",
"known",
"hypersensitivity",
"to",
"prostaglandins",
",",
"prostacyclin",
"or",
"treprostinil"
] |
[
0,
0,
0,
0,
0,
4,
0,
4,
0,
4
] |
NCT02162511
|
37:58:treatment
|
Participant does not qualify for an allogeneic transplant due to medical screening, underlying disease, or lack of alternative donors
| 1
|
[
"Participant",
"does",
"not",
"qualify",
"for",
"an",
"allogeneic",
"transplant",
"due",
"to",
"medical",
"screening",
",",
"underlying",
"disease",
",",
"or",
"lack",
"of",
"alternative",
"donors"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02338999
|
18:38:chronic_disease,42:51:chronic_disease,68:84:treatment
|
Prior history of hemorrhagic cystitis or hematuria while receiving cyclophosphamide that could not be explained by other causes
| 1
|
[
"Prior",
"history",
"of",
"hemorrhagic",
"cystitis",
"or",
"hematuria",
"while",
"receiving",
"cyclophosphamide",
"that",
"could",
"not",
"be",
"explained",
"by",
"other",
"causes"
] |
[
0,
0,
0,
2,
2,
0,
2,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01532687
|
13:40:chronic_disease
|
Symptomatic peripheral vascular disease
| 1
|
[
"Symptomatic",
"peripheral",
"vascular",
"disease"
] |
[
0,
2,
2,
2
] |
NCT01807897
|
21:40:treatment,
|
No change in active cardiac medications for 4 weeks prior to randomization
| 1
|
[
"No",
"change",
"in",
"active",
"cardiac",
"medications",
"for",
"4",
"weeks",
"prior",
"to",
"randomization"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02343042
|
52:64:treatment
|
In the expansion arm at RP2D, patients must not be pomalidomide refractory
| 1
|
[
"In",
"the",
"expansion",
"arm",
"at",
"RP2D",
",",
"patients",
"must",
"not",
"be",
"pomalidomide",
"refractory"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02193191
|
1:8:chronic_disease,9:28:chronic_disease,29:46:chronic_disease
|
Medical/psychiatric illness/social situations that would limit compliance with study requirements as determined by the treating physician
| 1
|
[
"Medical/psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements",
"as",
"determined",
"by",
"the",
"treating",
"physician"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01903330
|
12:29:chronic_disease,31:59:chronic_disease,64:87:chronic_disease,
|
History of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 6 months prior to Day 1
| 1
|
[
"History",
"of",
"abdominal",
"fistula",
",",
"gastrointestinal",
"perforation",
",",
"or",
"intra-abdominal",
"abscess",
"within",
"6",
"months",
"prior",
"to",
"Day",
"1"
] |
[
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01908777
|
1:42:cancer
|
Hepatosplenic Gamma Delta T cell lymphoma
| 1
|
[
"Hepatosplenic",
"Gamma",
"Delta",
"T",
"cell",
"lymphoma"
] |
[
3,
3,
3,
3,
3,
3
] |
NCT01584076
|
1:19:treatment,
|
Strabismus surgery planned within 22 weeks
| 1
|
[
"Strabismus",
"surgery",
"planned",
"within",
"22",
"weeks"
] |
[
1,
1,
0,
0,
0,
0
] |
NCT03078504
|
24:28:treatment,
|
successfully tolerated CRRT for at least 4 hours without clotting or hemodynamic instability
| 1
|
[
"successfully",
"tolerated",
"CRRT",
"for",
"at",
"least",
"4",
"hours",
"without",
"clotting",
"or",
"hemodynamic",
"instability"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02857218
|
20:39:chronic_disease
|
Patients must have regional adenopathy
| 1
|
[
"Patients",
"must",
"have",
"regional",
"adenopathy"
] |
[
0,
0,
0,
2,
2
] |
NCT02503709
|
21:37:cancer,41:65:cancer,141:157:cancer,191:225:treatment,,244:253:treatment,263:271:treatment,275:301:treatment
|
Patients with known brain metastases or carcinomatous meningitis are excluded from this clinical trial, with the exception of patients with brain metastatic disease that has previously been treated and remained stable on MRI >= 2 months after treatment, without steroids or anti-epileptic medications; these patients may be enrolled at the discretion of the principal investigator
| 1
|
[
"Patients",
"with",
"known",
"brain",
"metastases",
"or",
"carcinomatous",
"meningitis",
"are",
"excluded",
"from",
"this",
"clinical",
"trial",
",",
"with",
"the",
"exception",
"of",
"patients",
"with",
"brain",
"metastatic",
"disease",
"that",
"has",
"previously",
"been",
"treated",
"and",
"remained",
"stable",
"on",
"MRI",
">",
"=",
"2",
"months",
"after",
"treatment",
",",
"without",
"steroids",
"or",
"anti-epileptic",
"medications",
";",
"these",
"patients",
"may",
"be",
"enrolled",
"at",
"the",
"discretion",
"of",
"the",
"principal",
"investigator"
] |
[
0,
0,
0,
3,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02390752
|
25:42:chronic_disease,,
|
patients with confirmed Gilberts syndrome, the TBil should be less than or equal to 1.5 (SqrRoot) ULN
| 1
|
[
"patients",
"with",
"confirmed",
"Gilberts",
"syndrome",
",",
"the",
"TBil",
"should",
"be",
"less",
"than",
"or",
"equal",
"to",
"1.5",
"(",
"SqrRoot",
")",
"ULN"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03121352
|
15:28:treatment,34:74:treatment,82:91:treatment,93:103:treatment
|
Patients with prior therapy with antibodies that modulate T-cell function (e.g., anti-PD-1, anti-PD-L1)
| 1
|
[
"Patients",
"with",
"prior",
"therapy",
"with",
"antibodies",
"that",
"modulate",
"T-cell",
"function",
"(",
"e.g.",
",",
"anti-PD-1",
",",
"anti-PD-L1",
")"
] |
[
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0
] |
NCT03070899
|
12:26:treatment
|
History of uterus surgery that would interfere with the study
| 1
|
[
"History",
"of",
"uterus",
"surgery",
"that",
"would",
"interfere",
"with",
"the",
"study"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.